Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's software version was updated from v3.5.3 to v3.5.4. This indicates a newer release of the site's record-history UI and related components.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s display footer revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a maintenance or release update for the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check44 days agoChange DetectedReplimune, Inc. was added and Replimune Inc. was removed. Revision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.2%

- Check73 days agoChange DetectedA new revision entry v3.5.0 was added to the history and the previous entry v3.4.3 was removed.SummaryDifference0.1%

- Check87 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2 from the page's history.SummaryDifference0.1%

- Check102 days agoChange DetectedNew entries were added to the record history: 'Study Status' on 2026-02-13 and a value '43' on 2026-02-12, with a deletion recorded on 2025-12-17.SummaryDifference0.2%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.